Manufacturing Microbiome Therapeutics: Working with Living, Complex Products
Microbiome therapeutics present manufacturing challenges that differ from those associated with many conventional pharmaceutical products. Many contain living microorganisms or complex microbial communities, meaning factors such as viability, biological variability, processing conditions and storage must be considered throughout manufacture. These considerations apply across the microbiome therapeutics field, from defined live biotherapeutic products (LBPs) to complex […]